Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
opioid |
| gptkbp:administeredBy |
oral
intramuscular injection subcutaneous injection |
| gptkbp:ATCCode |
gptkb:N02AA08
|
| gptkbp:brand |
gptkb:DHC_Continus
gptkb:Dico Codhydrone DF118 Dihydrin Dihydrocodeine Tartrate Drocode Paracodin Synalgos DC Tussipax |
| gptkbp:broadcastOn |
Schedule 5 (UK)
Schedule II (US, when in single ingredient form) Schedule III (US, in combination products) |
| gptkbp:CASNumber |
125-28-0
|
| gptkbp:chemicalFormula |
C18H23NO3
|
| gptkbp:contraindication |
acute asthma
paralytic ileus respiratory insufficiency |
| gptkbp:developedBy |
gptkb:Germany
|
| gptkbp:developedYear |
1911
|
| gptkbp:discoveredBy |
gptkb:Georg_Merck
|
| gptkbp:eliminationHalfLife |
3.5-5 hours
|
| gptkbp:excretion |
kidneys
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dihydrocodeine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:MeSH_ID |
D003707
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
B3 (Australia) |
| gptkbp:PubChem_CID |
CHEMBL1201207
DB00454 5362440 |
| gptkbp:relatedTo |
gptkb:codeine
gptkb:morphine hydrocodone |
| gptkbp:riskFactor |
addiction
respiratory depression |
| gptkbp:sideEffect |
nausea
vomiting constipation dizziness itching drowsiness |
| gptkbp:UNII |
L5W6D9P6LL
|
| gptkbp:usedFor |
pain management
cough suppression dyspnea treatment |
| gptkbp:bfsParent |
gptkb:DHC_Oral_Syrup
|
| gptkbp:bfsLayer |
7
|